Revitalizing Europe's Pharma Industry

Crawford, Alex

• This article was written by Alex Crawford, a science writer based in the United Kingdom.

Reprints of this article are available from D&MD Publications. For more information visit http://www.drugandmarket.com, or write to [email protected], specifying the article title, volume, and issue number in your message.

D & MD Newsletter 13(5):p 152-157, May 2002.

• The European Union is considering recommendations about how best to make its pharmaceutical industry competitive in the global marketplace. Some want EU pharma businesses to be allowed the same freedom to operate enjoyed by US companies, while others want European companies to operate under strictures that favor the public more.

• Among the issues to be sorted through are the effect of generics on profitability and whether direct-to-consumer advertising should be allowed greater penetration in the European markets.